Collecting Samples and Data for Amyloid Diseases Research
This observational study aims to create a collection of samples and information from people with amyloid diseases, including Multiple Myeloma. Researchers will collect blood, urine, tissue, and bone marrow samples during your regular doctor visits. These samples will be used to analyze clonality (genetic makeup of cells), polymerase chain reaction (a lab technique to make many copies of a DNA segment), and proteins. The goal is to build a resource for future research to better understand amyloid diseases. You may be able to join if you are 18 or older, have a diagnosis or suspicion of amyloidosis, and are referred to the Amyloid Treatment and Research Center at Boston University Medical Center. The study is ongoing and plans to enroll up to 10,000 participants.
- Study design
- This is an observational study planning to enroll up to 10,000 participants. It is not a treatment study but focuses on collecting samples and data.
- What's involved
- You would provide blood, urine, tissue, and bone marrow samples during your standard laboratory evaluations.
- Compensation
- Not stated in the trial record.
- Follow-up
- Not specified.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Collection of Samples and Clinical Data From Patients With Amyloid Diseases
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Vaishali Sanchorawala, MD · PRINCIPAL_INVESTIGATOR · Boston Medical Center
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Establish a repository to promote biochemical researchlife of study